The combination of CB5138-2 — an experimental peptide, or small protein —  and Ofev (nintedanib) reduced symptoms of…
Articles by Forest Ray PhD
All patients in a Phase 1/2 trial examining two doses of AP01, an inhaled version of pirfenidone for the treatment…
A protein-coding gene called Spred2 may contribute to pulmonary fibrosis (PF) development, potentially representing a new therapeutic target,…
The American Thoracic Society (ATS) Research Program and 4DMedical are offering three one-year, $50,000 grants for research…
A protein called TL1A drives fibrosis in diseases such as idiopathic pulmonary fibrosis (IPF), asthma, and systemic sclerosis by…
Action for Pulmonary Fibrosis (APF) and the U.K. Royal College of General Practitioners (RCGP) have created and launched a…
The amount of bilirubin in the blood might predict the progression of idiopathic pulmonary fibrosis (IPF), according to…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
Galecto‘s investigational compound GB0139, now in an enrolling clinical trial, has been designated an orphan drug by the …
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…